Mark D. McKee

416 total citations
9 papers, 259 citations indexed

About

Mark D. McKee is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark D. McKee has authored 9 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark D. McKee's work include Breast Cancer Treatment Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Genomics and Diagnostics (2 papers). Mark D. McKee is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Genomics and Diagnostics (2 papers). Mark D. McKee collaborates with scholars based in United States, Germany and Canada. Mark D. McKee's co-authors include Gϋnter von Minckwitz, Sibylle Loibl, Charles E. Geyer, Joyce O’Shaughnessy, Mehra Golshan, David Maag, William M. Sikov, Jens Huober, Norman Wolmark and Danielle Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Mark D. McKee

9 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. McKee United States	7	137	107	80	47	44	9	259
Shuoer Wang China	10	124 0.9×	129 1.2×	159 2.0×	34 0.7×	54 1.2×	16	323
Peter Paluchowski Germany	9	109 0.8×	117 1.1×	84 1.1×	59 1.3×	48 1.1×	20	249
Xiaoji Ma China	11	195 1.4×	122 1.1×	102 1.3×	81 1.7×	43 1.0×	19	316
Roberta Porporato Italy	4	149 1.1×	103 1.0×	108 1.4×	70 1.5×	20 0.5×	7	263
Moubin Lin China	10	109 0.8×	118 1.1×	135 1.7×	45 1.0×	50 1.1×	18	316
Janani Jayanthan Australia	6	147 1.1×	107 1.0×	79 1.0×	52 1.1×	30 0.7×	8	264
Nazia Riaz Pakistan	9	130 0.9×	85 0.8×	85 1.1×	21 0.4×	53 1.2×	29	280
Yibin Lin China	9	107 0.8×	104 1.0×	147 1.8×	18 0.4×	39 0.9×	22	297
Melissa Lazar United States	9	84 0.6×	105 1.0×	108 1.4×	67 1.4×	57 1.3×	27	296
Natalia Ramírez-Merino Spain	6	236 1.7×	60 0.6×	160 2.0×	32 0.7×	107 2.4×	7	361

Countries citing papers authored by Mark D. McKee

Since Specialization

Citations

This map shows the geographic impact of Mark D. McKee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. McKee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. McKee more than expected).

Fields of papers citing papers by Mark D. McKee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. McKee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. McKee. The network helps show where Mark D. McKee may publish in the future.

Co-authorship network of co-authors of Mark D. McKee

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. McKee. A scholar is included among the top collaborators of Mark D. McKee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. McKee. Mark D. McKee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Golshan, Mehra, Sibylle Loibl, Stephanie M. Wong, et al.. (2020). Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. JAMA Surgery. 155(3). e195410–e195410. 89 indexed citations

Piha‐Paul, Sarina A., Jasgit C. Sachdev, Minal Barve, et al.. (2018). Results of the first-in-human study of ABBV-075 (mivebresib), a pan-inhibitor of bromodomain (BD) and extra terminal (BET) proteins, in patients (pts) with relapsed/refractory (R/R) solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 2510–2510. 8 indexed citations

Creelan, Ben, Dmitry I. Gabrilovich, Jhanelle E. Gray, et al.. (2017). Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors. OncoTargets and Therapy. Volume 10. 4239–4250. 41 indexed citations

Maitland, Michael L., Manish Sharma, Binsheng Zhao, et al.. (2017). Pharmaco-kinetics/dynamics (PK/PD) evaluation and individual patient cross-over studies with growth trajectory assessment to adaptively develop ilorasertib.. Journal of Clinical Oncology. 35(15_suppl). 2563–2563. 1 indexed citations

Golshan, Mehra, Sibylle Loibl, Jens Huober, et al.. (2017). Breast conservation after neoadjuvant chemotherapy for triple-negative breast cancer: Surgical results from an international randomized trial (BrighTNess).. Journal of Clinical Oncology. 35(15_suppl). 514–514. 2 indexed citations

Ramalingam, Suresh S., Normand Blais, Julien Mazières, et al.. (2016). Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(8). 1937–1944. 65 indexed citations

McKeegan, Evelyn, Peter Ansell, Gerard J. Davis, et al.. (2015). Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanib. Lung Cancer. 90(2). 296–301. 13 indexed citations

Horinouchi, Hidehito, Noboru Yamamoto, Hiroshi Nokihara, et al.. (2014). A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC). Cancer Chemotherapy and Pharmacology. 74(1). 37–43. 12 indexed citations

McKee, Mark D., et al.. (2002). Provider case volume and outcome in the evaluation and treatment of patients with mammogram‐detected breast carcinoma. Cancer. 95(4). 704–712. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact